T3 Companies »

Celldex Therapeutics shares owned by T3 Companies

Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by T3 Companies from 13F filings

Historical chart of T3 Companies investment in Celldex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Celldex Therapeutics held by T3 Companies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celldex Therapeutics by T3 Companies

Quarter filed Position value Share count Share price at filing
2026-06-30 $223k 6.0k 37.21

More positions owned by T3 Companies

Churchill Cap Corp Xi Cl A Ord Shs (CCXI)
Liquidia Corporation Com New (LQDA)
Futurecrest Acquisition Corp Cl A Ord Shs (FCRS)
Ishares Bitcoin Trust Etf Shs Ben Int Put Option (IBIT)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
A2z Cust2mate Solutions Corp (AZ)
New Era Helium Call Option (NUAI)
Electronic Arts (EA)
Advanced Micro Devices Call Option (AMD)
Space Exploration Techn Corp Class A Com Stk Call Option (SPCX)
Warner Bros Discovery Com Ser A Put Option (WBD)
New Amer Acquisition I Corp Unit 99/99/9999 (NWAX.U)
Nextnav Common Stock (NN)
Reddit Cl A (RDDT)
GBank Financial Holdings (GBFH)

View all positions for T3 Companies

Top funds holding Celldex Therapeutics

Wellington Management Company
BlackRock
Kynam Capital Management
FMR
Vanguard Capital Management
Deep Track Capital
State Street Corporation
Logos Global Management
T. Rowe Price Associates
Geode Capital Management
Eversept Partners
Goldman Sachs Group
Commodore Capital
Bellevue Group
Baker Bros. Advisors

View all funds holding Celldex Therapeutics